✦ LIBER ✦

P-62 Phase II trial of irinotecan plus cisplatin after cisplatin plus etoposide and concurrent thoracic radiotherapy (TRT) in small cell lung cancer (SCLC) patients with limited disease: West Japan Thoracic Oncology Group 9902

✍ Scribed by Ichinose, Yukito; Takada, Yoshiki; Matsui, Kaoru; Bessho, Akihiro; Kudoh, Shinzo; Nakagawa, Kazuhiko; Takada, Minoru; Negoro, Shunichi; Saito, Hiroshi; Ariyoshi, Yutaka

Book ID: 118571763
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 187 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92031-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-774 Phase II study of cisplatin plus e

P-774 Phase II study of cisplatin plus etoposide with concurrent thoracic radiotherapy (TRT) followed by innotecan plus cisplatin in limited stage small-cell lung cancer (SCLC); A West Japan Thoracic Oncology Group Trial

✍ Kashii, T.; Saito, H.; Negoro, S.; Takada, Y.; Ichinose, Y.; Matsui, K.; Eguchi, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

P-792 Phase II study of cisplatin plus e

P-792 Phase II study of cisplatin plus etoposide over 3 days combinedwith irinotecan and early thoracic radiotherapy (TRT) in patients with limited disease (LD) small cell lung cancer (SCLC), preliminary results

✍ Samantas, E.; Syrigos, K.; Briassoulis, E.; Bamias, A.; Koutras, A.; Karina, M.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Etoposide and cisplatin versus irinoteca

Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study

✍ Kubota, Kaoru; Hida, Toyoaki; Ishikura, Satoshi; Mizusawa, Junki; Nishio, Makoto 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 312 KB

P-58 Phase II study of irinotecan/cispla

P-58 Phase II study of irinotecan/cisplatin (IP) induction chemotherapy followed by concurrent twice-daily thoracic radiotherapy (RT) with etoposide/cisplatin (EP) for limited disease small cell lung cancer (LD-SCLC)

✍ Han, Ji-Youn; Cho, Kwan Ho; Lee, Dae Ho; Yoon, Seong Min; Kim, Hyae Young; Lee, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB

346 Cisplatin (P), ifosfamide (I), prolo

346 Cisplatin (P), ifosfamide (I), prolonged oral etoposide (E), and concurrent accelerated hyperfractionated thoracic radiotherapy (TRT) for patients with limited small cell lung cancer (LSCLC): Preliminary results of a phase II trial

✍ Glisson, B.; Scott, C.; Komaki, R.; Movsas, B.; Wagner, H. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

298 Feasibility study of concurrent cisp

298 Feasibility study of concurrent cisplatin/etoposide (PE) and thoracic radiotherapy (TRT) followed by weekly dose intensive regimen (CODE) with human granulocyte-colony stimulating factor (G-CSF) for limited stage (LS) small cell lung cancer (SCLC): Report of a Japan clinical oncology group study (JCOG-9509)

✍ Kubota, K.; Nishiwaki, Y.; Furuse, K.; Fukuoka, M.; Takada, M.; Ariyoshi, Y.; Ku 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 154 KB